Cancer Clinical Trial - Toray TRK-950

Cancer

Status:

Open (Study open and enrolling)

ClinicalTrials.gov:

NCT02990481

The major purposes of this study are to determine the maximum dose of TRK-950 that can be tolerated, and once this dose is found, if it has any effect in patients with solid cancer tumors.

Drug

TRK-950

Trial Type

Interventional

Age Range

18 years or older

Phase

Phase 1

Condition

Solid Tumors

Keywords

Toray | solid tumor | pancreas | TRK-950